Jason Momoa's Aquaman and the Lost Kingdom floats to top of box office but flounders with $28M opening Jason Momoa's Arthur Curry waves goodbye (or does he?) in Aquaman and the Lost Kingdom Jason ...

Princess Beatrice and Edoardo Mapelli Mozzi will welcome a new addition to their family next year, Buckingham Palace announced earlier this week. The couple, who married in July 2020, are ...

I write about commercial cinema technology and smart-home tech. Instead, we have the pairing of Jason Momoa’s Aquaman paired up with his half-brother, Orm played by Patrick Wilson. While Momoa ...

During Barack Obama's presidency, frustration among his supporters at unfulfilled campaign promises became so common that a political scientist coined a name for the phenomenon. These supporters ...

Princess Beatrice and her husband Edoardo Mapelli Mozzi are currently expecting their second child together Charlotte Walsh is a contributing writer at PEOPLE. She has been working at PEOPLE since ...

"So looking forward to more on this journey of motherhood together," Princess Eugenie wrote in the congratulatory post Janine Henni is a Royals Staff Writer for PEOPLE Digital, covering modern ...

Well, then you’ll be super impressed to see Mira Rajput’s latest fashion statement. The diva wore a classy midi dress, and she honestly rocked it with elegance. Want more summer-ready outfit ...

1 Day MIRA 10.19% DJIA -0.36% Russell 2K -0.27% Health Care/Life Sciences 0.06% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent ...

Sun Princess' fresher, more modern design may appeal to a younger crowd than the line normally caters to. Incredible dining options abound, including The Catch by Rudi and the new Spellbound ...

MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company engages in developing its product candidate, MIRA1a, as a synthetic cannabinoid analog ...

MIAMI, FL / ACCESSWIRE / October 21, 2024 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a leading pre-clinical-stage pharmaceutical development company, is excited to announce that its novel oral ...